Beijing Stemexcel Technology

Beijing Stemexcel Technology Co., Ltd. (Stemexcel) is a leading Chinese contract research organization (CRO) specializing in comprehensive clinical research services for the pharmaceutical and medical device industries. Founded in 2005 and headquartered in Beijing, the company provides a full suite of services including drug and medical device registration, Phase I-IV clinical trial management, patient recruitment, data management, and pharmacovigilance. Stemexcel is particularly recognized for its expertise in infectious diseases, oncology, vaccines, and rheumatology, having successfully managed over 300 clinical research and registration projects. The company utilizes its proprietary DAS for EDC electronic data capture system to enhance trial efficiency and data quality. With a team of over 250 professionals and a network of offices across China, Stemexcel supports both domestic and international clients in accelerating the development of innovative therapies.